Affiliation:
1. Division of Pharmacology and Toxicology, Department of Pharmacy Radboud University Medical Center Nijmegen The Netherlands
2. Department of Pediatric and Neonatal Intensive Care, Erasmus MC‐Sophia Children's Hospital Rotterdam The Netherlands
Abstract
It is well‐accepted that off‐label drug dosing recommendations for pediatric patients should be based on the best available evidence. However, the available traditional evidence is often low. To bridge this gap, physiologically‐based pharmacokinetic (PBPK) modeling is a scientifically well‐founded tool that can be used to enable model‐informed dosing (MID) recommendations in children in clinical practice. In this tutorial, we provide a pragmatic, PBPK‐based pediatric modeling workflow. For this approach to be successfully implemented in pediatric clinical practice, a thorough understanding of the model assumptions and limitations is required. More importantly, careful evaluation of an MID approach within the context of overall benefits and the potential risks is crucial. The tutorial is aimed to help modelers, researchers, and clinicians, to effectively use PBPK simulations to support pediatric drug dosing.
Subject
Pharmacology (medical),Pharmacology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献